Saturday, October 31, 2026

Monroe Capital Corporation And 4 Other Stocks Have Very High Payout Ratio

Monroe Capital Corporation And 4 Other Stocks Have Very High Payout Ratio

(VIANEWS) - Monroe Capital Corporation (MRCC), CVR Partners, LP (UAN), First Interstate BancSystem (FIBK) are the highest payout ratio stocks on this list.

We have congregated information about stocks with the highest payout ratio at the moment. The payout ratio in itself isn't a guarantee of good investment but it's an indicator of whether dividends are being paid and how the company chooses to issue them.

When investigating a potential investment, the dividend payout ratio is a good statistic to know so here are a few stocks with an above 30% percent payout ratio.

1. Monroe Capital Corporation (MRCC)

10000% Payout Ratio

Monroe Capital Corporation is a business development company specializing in customized financing solutions in senior, unitranche and junior secured debt and to a lesser extent, unsecured debt and equity, including equity co-investments in preferred and common stock and warrants. It also provides financing primarily to buyouts in lower middle-market companies. It focuses to invest in the United States and Canada. The fund prefers to invest in companies with EBITDA between $3 and $35 million.

Earnings Per Share

As for profitability, Monroe Capital Corporation has a trailing twelve months EPS of $0.01.

PE Ratio

Monroe Capital Corporation has a trailing twelve months price to earnings ratio of 760. Meaning, the purchaser of the share is investing $760 for every dollar of annual earnings.

The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 0.1%.

Moving Average

Monroe Capital Corporation's worth is above its 50-day moving average of $7.46 and higher than its 200-day moving average of $7.25.

Growth Estimates Quarters

The company's growth estimates for the ongoing quarter is a negative 3.7% and positive 4% for the next.

Dividend Yield

As maintained by Morningstar, Inc., the next dividend payment is on Jun 17, 2024, the estimated forward annual dividend rate is 1 and the estimated forward annual dividend yield is 13.32%.

Yearly Top and Bottom Value

Monroe Capital Corporation's stock is valued at $7.60 at 02:23 EST, way under its 52-week high of $8.85 and way above its 52-week low of $6.69.

2. CVR Partners, LP (UAN)

226.46% Payout Ratio

CVR Partners, LP, together with its subsidiaries, engages in the production and sale of nitrogen fertilizer products in the United States. The company offers ammonia products for agricultural and industrial customers; and urea ammonium nitrate products to agricultural customers, as well as retailers and distributors. CVR GP, LLC serves as the general partner of the company. CVR Partners, LP was incorporated in 2007 and is based in Sugar Land, Texas. CVR Partners, LP is a subsidiary of CVR Energy, Inc.

Earnings Per Share

As for profitability, CVR Partners, LP has a trailing twelve months EPS of $7.86.

PE Ratio

CVR Partners, LP has a trailing twelve months price to earnings ratio of 10.02. Meaning, the purchaser of the share is investing $10.02 for every dollar of annual earnings.

The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 23.74%.

Dividend Yield

As stated by Morningstar, Inc., the next dividend payment is on May 10, 2024, the estimated forward annual dividend rate is 9.29 and the estimated forward annual dividend yield is 11.8%.

Yearly Top and Bottom Value

CVR Partners, LP's stock is valued at $78.75 at 02:23 EST, way below its 52-week high of $94.38 and way higher than its 52-week low of $60.50.

Moving Average

CVR Partners, LP's value is below its 50-day moving average of $79.59 and above its 200-day moving average of $75.10.

Volume

Today's last reported volume for CVR Partners, LP is 35852 which is 6.51% above its average volume of 33659.

3. First Interstate BancSystem (FIBK)

74.9% Payout Ratio

First Interstate BancSystem, Inc. operates as the bank holding company for First Interstate Bank that provides range of banking products and services in the United States. It offers various traditional depository products, including checking, savings, and time deposits; and repurchase agreements primarily for commercial and municipal depositors. The company also offers real estate loans comprising commercial real estate, construction, residential, agricultural, and other real estate loans; consumer loans comprising direct personal loans, credit card loans and lines of credit, and indirect loans; variable and fixed rate commercial loans for small and medium-sized manufacturing, wholesale, retail, and service businesses for working capital needs and business expansions; and agricultural loans. In addition, it provides a range of trust, employee benefit, investment management, insurance, agency, and custodial services to individuals, businesses, and nonprofit organizations. Further, the company offers marketing, credit review, loan servicing, credit cards issuance and servicing, mortgage loan sales and servicing, indirect consumer loan purchasing and processing, loan collection services, and other operational services, as well as online and mobile banking services. It serves individuals, businesses, municipalities, and other entities in various industries, including agriculture, construction, education, energy, governmental services, healthcare, hospitality, housing, mining, professional services, real estate development, retail, technology, tourism, and wholesale trade. As of December 31, 2021, it operated 147 banking offices, including detached drive-up facilities in communities across Idaho, Montana, Oregon, South Dakota, Washington, and Wyoming. The company was incorporated in 1971 and is headquartered in Billings, Montana.

Earnings Per Share

As for profitability, First Interstate BancSystem has a trailing twelve months EPS of $2.51.

PE Ratio

First Interstate BancSystem has a trailing twelve months price to earnings ratio of 10.83. Meaning, the purchaser of the share is investing $10.83 for every dollar of annual earnings.

The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 8.15%.

Growth Estimates Quarters

The company's growth estimates for the ongoing quarter and the next is a negative 15.4% and a negative 18.6%, respectively.

4. Hanover Insurance Group (THG)

74.61% Payout Ratio

The Hanover Insurance Group, Inc., through its subsidiaries, provides various property and casualty insurance products and services in the United States. The company operates through four segments: Core Commercial, Specialty, Personal Lines, and Other. The Commercial Lines segment offers commercial multiple peril, commercial automobile, workers' compensation, and other commercial lines coverage. The Specialty segment provides professional and executive Lines, marine, and surety and other, as well as specialty property and casualty, such as program business, specialty industrial business, excess and surplus business, and specialty general liability coverage. The Personal Lines segment offers personal automobile and homeowner's coverages, as well as other personal coverages, such as personal umbrella, inland marine, fire, personal watercraft, personal cyber, and other miscellaneous coverages. The Other segment markets investment advisory services to institutions, insurance companies, pension funds, and other organizations. The Hanover Insurance Group, Inc. markets its products and services through independent agents and brokers. The company was formerly known as Allmerica Financial Corp. and changed its name to The Hanover Insurance Group, Inc. in December 2005. The Hanover Insurance Group, Inc. was founded in 1852 and is headquartered in Worcester, Massachusetts.

Earnings Per Share

As for profitability, Hanover Insurance Group has a trailing twelve months EPS of $4.45.

PE Ratio

Hanover Insurance Group has a trailing twelve months price to earnings ratio of 27.85. Meaning, the purchaser of the share is investing $27.85 for every dollar of annual earnings.

The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 6.56%.

5. Alliancebernstein Global High Income Fund (AWF)

53.84% Payout Ratio

AllianceBernstein Global High Income Fund is a close-ended fixed income mutual fund launched and managed by AllianceBernstein L.P. It invests in fixed income markets across the globe. The fund primarily invests in lower-rated corporate debt securities and government bonds. It employs a combination of fundamental and quantitative analysis to create its portfolio. The fund benchmarks the performance of its portfolio against a composite index comprised of JPMorgan Government Bond Index-Emerging Markets, JPMorgan Emerging Markets Bond Index Global, and the Barclays U.S. Corporate High Yield 2% Issuer Capped Index. It was previously known as Alliance World Dollar Government Fund II, Inc. AllianceBernstein Global High Income Fund was formed on May 20, 1993 and is domiciled in the United States.

Earnings Per Share

As for profitability, Alliancebernstein Global High Income Fund has a trailing twelve months EPS of $1.46.

PE Ratio

Alliancebernstein Global High Income Fund has a trailing twelve months price to earnings ratio of 7.21. Meaning, the purchaser of the share is investing $7.21 for every dollar of annual earnings.

The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 13.32%.

Yearly Top and Bottom Value

Alliancebernstein Global High Income Fund's stock is valued at $10.53 at 02:23 EST, under its 52-week high of $10.83 and way higher than its 52-week low of $9.20.

Dividend Yield

As claimed by Morningstar, Inc., the next dividend payment is on Jun 6, 2024, the estimated forward annual dividend rate is 0.79 and the estimated forward annual dividend yield is 7.5%.

Moving Average

Alliancebernstein Global High Income Fund's value is below its 50-day moving average of $10.53 and above its 200-day moving average of $10.16.

1. 1 (1)

1% Payout Ratio

1

Earnings Per Share

As for profitability, 1 has a trailing twelve months EPS of $1.

PE Ratio

1 has a trailing twelve months price to earnings ratio of 1. Meaning, the purchaser of the share is investing $1 for every dollar of annual earnings.

The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 1%.

Earnings Before Interest, Taxes, Depreciation, and Amortization

1's EBITDA is 1.

Volatility

1's last week, last month's, and last quarter's current intraday variation average was 1.00%, 1.00%, and 1.00%.

1's highest amplitude of average volatility was 1.00% (last week), 1.00% (last month), and 1.00% (last quarter).

Growth Estimates Quarters

The company's growth estimates for the ongoing quarter and the next is 1% and 1%, respectively.

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
ESMO 2026 Oncology Catalyst Cluster: Ivonescimab's PDUFA Date and Small-Cap Biotech Delistings
ESMO 2026 (Oct 22-24) concentrates a wave of oncology readouts. Summit's ivonescimab (10 presentations, positive HARMONi-GI1 OS, new EA2251 Phase II/III with ECOG-ACRIN) leads, ahead of its FDA PDUFA date of 2026-11-14, and Daiichi Sankyo's DXd ADC platform (REJOICE-Ovarian, DESTINY-Lung04, TUXEDO-3) follows. At the other end of the capital-markets spectrum, micro-cap Spago Nanomedical is moving to delist from Nasdaq First North (board resolution Oct 22, EGM Nov 19, application Jan 2027). Pivotal data and regulatory milestones are rewarding well-funded late-stage players, while cash-constrained early-stage developers are exiting public markets.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,995
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,995 facts checked against source5,525 source documents archived
Query this data → isubstrate.com